Newborn screening for rare cystinosis and hyperoxaluria
Part of Genetic & congenital, Hormones & metabolism, Kidney & urinary, Women’s health & pregnancy clinical trials.
This study offers genetic screening to newborns to look for two rare metabolic conditions. It helps doctors find these conditions earlier, so treatment can start sooner if needed.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be a newborn enrolled in the study’s genetic newborn screening program
- Have a parent or guardian provide consent for the screening
- Participate at the study site or through the program’s newborn screening process
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial looks at the use of cysteamine to treat cystinosis, a rare inherited condition. It may help lower harmful cystine buildup in the body and improve outcomes, especially early in life.
This study collects and stores donated samples (like blood, urine, and tissue) from people with certain rare inherited kidney stone conditions. The goal is to build a resource for future research that could help improve diagnosis and treatment.
This study gathers information from people with cystinosis to learn more about the condition. You may be able to join if you have a confirmed diagnosis.
This trial offers free genetic screening for rare diseases in newborns. It aims to find health conditions early so babies can get the right care sooner.
This study tests a new way to screen newborns for rare genetic diseases using a blood sample. It aims to find treatable conditions early so that babies can get care sooner.
This study offers fast genetic testing for newborns who have abnormal results on routine screens or unexplained health problems like low muscle tone, seizures, odd lab results, or bone issues. The goal is to quickly find possible genetic causes to help guide care.
Hear when a new Cystinosis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.